Sartorius Stedim Biotech (SDMHF) News Today $178.00 -6.69 (-3.62%) (As of 11/18/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period UBS Remains a Hold on Sartorius Stedim Biotech (0RG8)October 3, 2024 | markets.businessinsider.comGoldman Sachs upgrades Sartorius Stedim Biotech (0RG8) to a BuyOctober 3, 2024 | markets.businessinsider.comRBC Capital Sticks to Their Buy Rating for Sartorius Stedim Biotech (0RG8)September 2, 2024 | markets.businessinsider.comSartorius Stedim Biotech SA: Declaration Relative to the Number of Shares and Voting Rights Making up the Issued CapitalAugust 4, 2024 | finanznachrichten.deSartorius Stedim Biotech is about to announce its earnings — here's what Wall Street expectsApril 17, 2024 | markets.businessinsider.comSartorius Stedim Biotech SA ADR SRTOYFebruary 28, 2024 | morningstar.comSartorius Stedim Biotech S.A. (SDMHF)February 20, 2024 | finance.yahoo.comSartorius Stedim Biotech Shares Fall After Capital IncreaseFebruary 7, 2024 | marketwatch.comSartorius Stedim Biotech Completes $1.3 Bln Capital IncreaseFebruary 7, 2024 | marketwatch.comSartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlookJanuary 26, 2024 | markets.businessinsider.comSARTORIUS (SARTF) Q3 Earnings Lag EstimatesOctober 19, 2023 | finance.yahoo.comSartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim BiotechJuly 21, 2023 | markets.businessinsider.comSartorius Stedim Biotech H1 Profit, Orders Down; Backs Weak FY23 OutlookJuly 21, 2023 | markets.businessinsider.comSartorius Stedim Biotech Q1 Profit Declines, Sales Revenue Down 18.4% Organically; Confirms OutlookApril 20, 2023 | markets.businessinsider.comSartorius Stedim Biotech FY22 Profit Rises, Orders Down; Sees Growth In FY23; Raises FY25 Sales ViewJanuary 26, 2023 | markets.businessinsider.comPreliminary results 2022 of Sartorius Stedim BiotechJanuary 26, 2023 | technews.tmcnet.comNine-month results 2022 of Sartorius Stedim BiotechOctober 19, 2022 | finance.yahoo.comSartorius Stedim Biotech H1 Profit Climbs; Confirms FY22 Outlook - Quick FactsJuly 21, 2022 | markets.businessinsider.comSartorius Stedim Earnings Miss, Revenue Beats In Q1April 21, 2022 | investing.comSartorius Stedim Biotech S.A. Non-GAAP EPS of €2.21, revenue of €862.5MApril 21, 2022 | seekingalpha.comSartorius Stedim acquires Novasep's chromatography division; boosts sales guidanceFebruary 8, 2022 | seekingalpha.comSartorius Stedim Biotech Non-GAAP EPS of €7.46, revenue of €2.89BJanuary 28, 2022 | seekingalpha.comSingle-use Bioreactors Market worth $8.8 billion by 2026 – Major Players are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US)November 17, 2021 | benzinga.comLooking for a Growth Stock? 3 Reasons Why SARTORIUS (SARTF) is a Solid ChoiceNovember 16, 2021 | finance.yahoo.comMcMaster, Sartorius Stedim Biotech team up to advance biomanufacturing processes with next-gen techAugust 23, 2021 | finance.yahoo.com Get Sartorius Stedim Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for SDMHF and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW SDMHF Media Mentions By Week SDMHF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SDMHF News Sentiment▼0.000.52▲Average Medical News Sentiment SDMHF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SDMHF Articles This Week▼00▲SDMHF Articles Average Week Get Sartorius Stedim Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for SDMHF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ANSLY News ANSLF News CZMWY News CLPBF News CNVVY News GRRMF News INND News LUCYW News NNCSF News OLYMY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SDMHF) was last updated on 11/19/2024 by MarketBeat.com Staff From Our PartnersTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sartorius Stedim Biotech S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sartorius Stedim Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.